Jessica Chubak, PhD

“My research focuses on improving cancer control by finding effective ways to get screened for cancer and to navigate treatment and survivorship.”

Jessica Chubak, PhD

Associate Investigator, Kaiser Permanente Washington Health Research Institute

Biography

Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Based on a personal interest in how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies. She is the Kaiser Permanente Washington Health Research Institute (KPWHRI) principal investigator for the National Cancer Institute's Cancer Research Network.

Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington. Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the University of Washington School of Public Health where she enjoys guest lecturing and getting to work with students. 

Research interests and experience

  • Cancer

    Epidemiology; colorectal cancer; medication use; survivorship; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship

  • Health Services & Economics

    Chronic illness management; translation of preventive care research into clinical practice

  • Medication Use & Patient Safety

    Cancer risk and use of common medications; pharmaceutical outcomes research; validation of pharmacy data resources

 

Recent publications

Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Diabetes treatments and risks of adverse breast cancer outcomes among early stage breast cancer patients: a SEER-Medicare analysis. Cancer Res. 2017 Nov 1;77(21):6033-6041. doi: 10.1158/0008-5472.CAN-17-0687. Epub 2017 Sep 21. PubMed

Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-Medicare population. Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1603-1610. doi: 10.1158/1055-9965.EPI-17-0346. Epub 2017 Aug 14. PubMed

Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Meenan RT, Vernon SW. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: a randomized trial. Cancer. 2017 Nov 15;123(22):4472-4480. doi: 10.1002/cncr.30908. Epub 2017 Jul 28. PubMed

Chubak J, Hawkes R, Dudzik C, Foose-Foster JM, Eaton L, Johnson RH, Macpherson CF. Pilot study of therapy dog visits for inpatient youth with cancer. J Pediatr Oncol Nurs. 2017 Sep/Oct;34(5):331-341. doi: 10.1177/1043454217712983. Epub 2017 Jun 14. PubMed

 

Latest News

Therapy-dog visits for kids with cancer: A safe way to induce smiles?

Being in the hospital is stressful. A new KPWHRI study will see if visits from therapy dogs make the experience easier for pediatric cancer patients.

Read it in News and Events.

Cancer Screening

Group Health’s lifesaving approach to screening for colon cancer takes another step forward

Research shows innovative approach serves health care consumers over long term.

Read it in News and Events.

Healthy Findings blog

Dr. Jessica Chubak and team ROAR: Research on Animal-human Relationships

A study to help kids with cancer get time with pets begins field work, with encouragement from a GHRI interest group.

Read about it in Healthy Findings.